About the Authors

Mireia Arnedo, Jose Maria Gatell
Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain

Elena Alonso, Nell Eisenberg, Cecilia Ferreyra, Laurence Flevaud, Paul Roddy
Médécins sans Frontières-Operational Center Barcelona Athens, Barcelona, Spain

Laura Ibáñez, Angels Jaén, David Dalmau
Fundació Docència i Recerca MutuaTerrassa, Terrassa, Spain

Samuel Khamadi
Kenya Medical Research Institute (KEMRI), Nairobi, Kenya

David Dalmau
Hospital Universitari MútuaTerrassa, Medicine Department, Terrassa, Spain

Corresponding Author

ddalmau@mutuaterrassa.cat

Competing Interests

D Dalmau and JM Gatell have been a consultant on advisory boards, have participated in speakers' bureaus, have received research grants or have conducted clinical trials with Roche, Boehringer Ingelheim, Abbott, BMS, GSK, Gilead, Janssen, Merck and Pfizer. M. Arnedo, E. Alonso, N. Eisenberg, L. Ibáñez, C. Ferreyra, A. Jaén, L. Flevaud, S. Khamadi, P. Roddy, J. Mashala, A. Alvarez and E. Velilla report no conflicts of interest relevant to this article. No other potential conflict of interest relevant to this article was reported. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: DD MA EA NE. Performed the experiments: MA LI LF. Analyzed the data: DD AJ PR MA. Contributed reagents/materials/analysis tools: MA LI LF AJ DD SK. Wrote the paper: DD MA. Reviewed and edited manuscript: EA NE LI CF AJ LF SK PR JMG.